Skip to main content

Peer Review reports

From: Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity

Original Submission
30 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Apr 2023 Reviewed Reviewer Report
18 Apr 2023 Reviewed Reviewer Report
23 Apr 2023 Author responded Author comments - Yuan-Xiang Shi
Resubmission - Version 3
23 Apr 2023 Submitted Manuscript version 3
24 Apr 2023 Author responded Author comments - Yuan-Xiang Shi
Resubmission - Version 4
24 Apr 2023 Submitted Manuscript version 4
Publishing
27 Apr 2023 Editorially accepted
6 May 2023 Article published 10.1186/s12885-023-10895-2

You can find further information about peer review here.

Back to article page